LitonRx

LitonRx

Early Stage

Digital Solutions for Your Prescription

Digital Solutions for Your Prescription

Overview

Raised this Round: Raised: $128,749

Total Commitments ($USD)

Platform

StartEngine

Start Date

09/22/2022

Close Date

12/23/2022

Min. Goal
$10,000
Max. Goal
$1,235,000
Min. Investment

$500

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$1.00

Pre-Money Valuation

$25,000,000

Year Founded

2022

Industry

Healthcare & Pharmaceuticals

Tech Sector

Medtech

Distribution Model

B2C

Margin

High

Capital Intensity

Low

Location

Chandler, Arizona

Business Type

High Growth

LitonRx, with a valuation of $25 million, is raising funds on StartEngine. The company offers affordable and subscription-based digital pharmacy and concierge virtual care services. LitonRx is developing its product, LitonMD, to offer free same-day delivery of covered formulary prescription medications. The platform will also provide concierge physicians and medications on a low monthly subscription model. Kishlay Anand founded LitonRx in July 2022. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,235,000. The campaign proceeds will be used for expansion to additional states and growth of revenue.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$518,090

$0

COGS

$471,419

$0

Tax

$0

$0

 

 

Net Income

$-530,361

$-69,584

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$506,175

$16,451

Accounts Receivable

$71,879

$0

Total Assets

$801,961

$27,851

Short-Term Debt

$35,675

$3,422

Long-Term Debt

$0

$0

Total Liabilities

$35,675

$3,422

Financials as of: 09/22/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
LitonRx on StartEngine 2022
Platform: StartEngine
Security Type: Equity - Common
Valuation: $25,000,000
Price per Share: $1.00

Follow company

Follow LitonRx on StartEngine 2022

Buy LitonRx's Deal Report

Warning: according to the close date for this deal, LitonRx may no longer be accepting investments.

LitonRx Deal Report

Get KingsCrowd’s comprehensive report on LitonRx including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether LitonRx is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the LitonRx deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge